Genpact Limited Declares Quarterly Dividend of $0.15 (NYSE:G)

Genpact Limited (NYSE:GGet Free Report) declared a quarterly dividend on Friday, October 18th, Wall Street Journal reports. Shareholders of record on Monday, December 9th will be given a dividend of 0.1525 per share by the business services provider on Monday, December 23rd. This represents a $0.61 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date is Monday, December 9th.

Genpact has increased its dividend by an average of 12.1% annually over the last three years. Genpact has a dividend payout ratio of 18.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Genpact to earn $3.02 per share next year, which means the company should continue to be able to cover its $0.61 annual dividend with an expected future payout ratio of 20.2%.

Genpact Stock Performance

Genpact stock opened at $38.95 on Friday. Genpact has a fifty-two week low of $29.41 and a fifty-two week high of $39.95. The firm’s fifty day moving average price is $38.82 and its 200-day moving average price is $34.70. The stock has a market cap of $7.01 billion, a P/E ratio of 11.13, a price-to-earnings-growth ratio of 1.63 and a beta of 1.13. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.89 and a current ratio of 1.89.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.05. Genpact had a return on equity of 22.28% and a net margin of 14.12%. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.15 billion. On average, equities research analysts expect that Genpact will post 2.85 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

G has been the subject of several research reports. JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Robert W. Baird increased their target price on shares of Genpact from $38.00 to $44.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. Jefferies Financial Group lifted their target price on shares of Genpact from $35.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 9th. Needham & Company LLC upped their price target on shares of Genpact from $40.00 to $42.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, BMO Capital Markets lifted their price objective on Genpact from $38.00 to $42.00 and gave the stock a “market perform” rating in a report on Monday, August 12th. Eight analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $39.44.

Read Our Latest Stock Report on G

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Dividend History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.